Novel oral anticoagulants for heparin-induced thrombocytopenia. - Wikidata - wikimedia - TriplyDB

Novel oral anticoagulants for heparin-induced thrombocytopenia.

Novel oral anticoagulants for heparin-induced thrombocytopenia.

http://www.wikidata.org/entity/Q33431683

about

Thrombocytopenia induced by dabigatran: two case reports Extensive Intracardiac and Deep Venous Thromboses in a Young Woman with Heparin-Induced Thrombocytopenia and May-Thurner Syndrome.Direct acting oral anticoagulants for the treatment of suspected heparin induced thrombocytopenia.Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia.Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review.New Indications for Dabigatran: A Suggestion from a Drug Use Evaluation Study.Cutaneous Drug Reactions in the Elderly.

P2860

Q32179630-8D89FCE7-D1D3-40C0-ACFE-0821996BA8C1 Q33441557-E75E43AD-3196-48B9-B0E3-4CDD15E97C16 Q33443237-B32F3BE1-BB1C-4D72-B65B-68C20D3E1DE8 Q36301795-EDDC7469-5546-4F6E-91FB-D65E45D9EFB8 Q41618431-F63003BF-7DFF-48D7-88BC-B1B8B1ED73C0 Q42354537-DDD582FE-69C7-45B6-B983-D3C09F21F461 Q49275825-B7ACD049-7B7C-416F-9E6D-527CA0B28F01 Q51803601-44B98409-C8A3-438C-91BE-ABCE78C5679B

P2860

Novel oral anticoagulants for heparin-induced thrombocytopenia.

http://www.wikidata.org/entity/Q33431683

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@ast

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@en

type

label

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@ast

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@en

prefLabel

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@ast

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@en

P1433

Q33431683-693FE452-7E39-467B-BBF8-87076D58DD81

P1476

Q33431683-E56B54A0-1989-47E4-AF5C-8AA0BA7C60A9

P2093

Q33431683-3F59DE5C-F2C5-4926-9E3D-C7A64862FBD8

Q33431683-B3C4C7A3-5F68-48AC-875C-BCF681FE7B9A

Q33431683-F57A5154-DAD9-4A0F-ADB0-E3B3D204F03C

P2860

Q33431683-05140BD9-C1D4-47C2-9741-D2D5D7D88D0E

Q33431683-0CFEA7FF-81F5-4EE3-82C0-9E15AC754125

Q33431683-143E5A93-5BAE-41DC-891B-D0B54D9B4635

Q33431683-1F431005-D724-4384-8140-7D2186057E50

Q33431683-1FACF586-9253-4F96-A3C0-56FBDC611A75

Q33431683-343DE99D-41A9-412F-8F47-E4DABE00A6F9

Q33431683-3E4FD755-213E-4852-B546-3AF20DA65982

Q33431683-5C931BF3-974F-43CF-B153-469353208AB9

Q33431683-69AF031B-C2E1-4B35-80B2-8CDEAFB77077

Q33431683-6F9D2DE0-E746-43CD-A9E0-92DFEF003B96

P2888

Q33431683-3A7D5BC5-B59F-4C58-A40F-260CA22A7171

P304

Q33431683-0B22DE35-4EAA-4E7F-9B28-77ECE9569122

P31

Q33431683-E427B610-B83D-4F3D-B77D-5DABEE17399C

P356

Q33431683-AD1EFF7B-CE74-4C1C-9B40-866147103279

P433

Q33431683-D791E837-8532-4138-A733-28735D0E8936

P478

Q33431683-A9A6D973-BF8F-4486-8DC7-48F45476B937

P577

Q33431683-835622A4-EF10-4E8E-9394-3F68C3342456

P698

Q33431683-B6792543-8198-4DE5-AB77-3D7A601E82C0

P921

Q33431683-56B90901-5CB9-4C1E-8469-D35EC35CA4B9

Q33431683-63A08793-7731-41C4-AFE9-EE54203FEA02

P356

S11239-016-1365-0

P1433

Journal of Thrombosis and Thrombolysis

P1476

Novel oral anticoagulants for heparin-induced thrombocytopenia.

@en

P2093

Jeffrey A Kyle

http://www.w3.org/2001/XMLSchema#string

Jessica W Skelley

http://www.w3.org/2001/XMLSchema#string

Rachel A Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Heparin induced thrombocytopenia: diagnosis and management update

Benefit-risk assessment of treatments for heparin-induced thrombocytopenia

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.

Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.

P2888

s11239-016-1365-0

P304

172-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-016-1365-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27102287

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

anticoagulation